Shattuck Labs, Inc. Public Float
Shattuck Labs, Inc. (STTK) had Public Float of $22.83 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $22.83M.
- 2024-06-30: Entity Public Float $102.10M.
- 2023-06-30: Entity Public Float $85.55M.
- 2022-06-30: Entity Public Float $110.52M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $22.83M 10-K · filed 2026-03-05 |
| 2024-06-30 | $102.10M 10-K/A · filed 2025-05-01 |
| 2023-06-30 | $85.55M 10-K · filed 2024-02-29 |
| 2022-06-30 | $110.52M 10-K · filed 2023-02-23 |
| 2021-06-30 | $690.08M 10-K · filed 2022-03-15 |
| 2020-10-14 | $553.52M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |